Biotech Scoreboard, November: Gene Therapy Stocks Gain Momentum

Here is the review we did on June 30 after a Barron’s article on the sector.

IBB up 11.2% for November, XBI up 6.3%, but NASDAQ-100 (QQQ) leads up 14.5 %.

Big Winners for the Month: NTLA up 47.24%, EDIT up 41.5%, CRSP up 37.68%, SRPT up 34%,

                 
                 
Company Symbol Price Price at   Price Mo./% YTD %  
    6/29/19 52 wk hi   11/30      
                 
Audentes Therap BOLD 37.86 42.7 1.67 29.03 14.5 30.71  
MetraGTx MGTX 26.88 27 0.896 19.27 10.2 95.93  
RegenexBio RGNX 51.37 85.1 1.88 41.86 21.2 (3.390  
Solid Biosci SLDB 5.75 54.54 0.37 3.93 -65.13 -86.41  
uniQure QURE 78.15 82.49 2.95 55.66 14.5 95  
Voyager Therap VYGR 27.22 28.79 0.612 13.64 14.49 44.8  
                 
Diversified Plays                
                 
Biomarin BMRN 85.65 106.74 15.337 80.71 9.8 -5  
Sarepta SRPT 151.95 165.87 11.27 112.49 34.04 4.64  
                 
Other                
                 
Amicus FOLD 12.48 16.82 3.174 10.48 26.4 4.36  
bluebird bio BLUE 127.2 183.6 7.012 80.94 -2.7 -18.65  
                 
Gene Editing                
                 
CRSPR Therap CRSP 47.1 66.26 2.58 71.65 37.68 139.87  
Editas Medicine EDIT 24.74 38.77 1.22 30.28 41.5 29.73  
Intellia Therap NTLA 16.37 35.3 0.748 17.33 47.24 25.5  
Sangamo Ther SGMO 10.77 -3.9 1.24 10.8 16.8 -8.32  
Cellectis S.A. CLLS       13.9 16 -19.94  
                 
IBB   109.1 122.97   119.65 11.2 22.72  
XBI   87.71 101.17   93.65 6.3 28.53  
                 
QQQ         205.17 14.5 32.43  
               

Disclosure: None.

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.